DrugBiological
Enlicitide chloride clinical trials
Also written MK-0616.
A product of Enlicitide; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
4 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses enlicitide chloride is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)CompletedPhase 1Merck Sharp & Dohme LLCNCT05070390Written as Enlicitide Chloride
- A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)CompletedPhase 1Merck Sharp & Dohme LLCNCT06814106Written as Enlicitide Chloride
- A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)CompletedPhase 1Merck Sharp & Dohme LLCNCT06658626Written as [¹⁴C]Enlicitide chloride
- A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT06655311Written as Enlicitide Chloride
Codes
What other systems call enlicitide chloride · ClinicalTrials.gg INT014649
- UNII (FDA) 3D2DNA8NXKENLICITIDE CHLORIDEOne source FDA
- NCI Thesaurus C199042Enlicitide ChlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3D2DNA8NXK | ENLICITIDE CHLORIDE | One source FDA |
| NCI Thesaurus | C199042 | Enlicitide Chloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.